Scancell Holdings plc, a clinical stage biopharmaceutical company, discovers and develops of immunotherapies for the treatment of cancer in the United Kingdom. Its product candidates include SCIB1/iSCIB1+ that is in Phase II for the treatment of melanoma; and SC134, an antibody for the treatment of ... Scancell Holdings plc, a clinical stage biopharmaceutical company, discovers and develops of immunotherapies for the treatment of cancer in the United Kingdom. Its product candidates include SCIB1/iSCIB1+ that is in Phase II for the treatment of melanoma; and SC134, an antibody for the treatment of small cell lung cancer. It also develops Modi-1, an active peptide immunotherapy that is in phase II clinical trials for the treatment of solid tumors, including renal, head and neck, ovarian and triple negative breast cancers; and Modi-2, which targets stress-induced post translational modifications, such as homocittrullination. In addition, the company provides GlyMab platform that generates various affinity tumour specific monoclonal antibodies (mAb) targeting glycans that are over-expressed on cancer cells; and AvidiMab, which romotes receptor clustering thereby improving immune signalling. Scancell Holdings plc was founded in 1996 and is based in Oxford, the United Kingdom. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -3.25 | -14.2857142857 | 22.75 | 22.8 | 18.25 | 1868080 | 20.44321924 | DE |
| 4 | -1.5 | -7.14285714286 | 21 | 29.5 | 18.25 | 3277032 | 22.99776948 | DE |
| 12 | 7.75 | 65.9574468085 | 11.75 | 29.5 | 11 | 2204580 | 18.8310383 | DE |
| 26 | 9.6 | 96.9696969697 | 9.9 | 29.5 | 9.75 | 1802120 | 15.97352435 | DE |
| 52 | 9.625 | 97.4683544304 | 9.875 | 29.5 | 7.9 | 1358881 | 13.79133324 | DE |
| 156 | 5.025 | 34.7150259067 | 14.475 | 29.5 | 7.25 | 960381 | 12.87837237 | DE |
| 260 | -2.1 | -9.72222222222 | 21.6 | 29.5 | 7.25 | 919713 | 14.91249104 | DE |
Curios George
2分前
fricassee
7分前
deepdj011
8分前
Bobsemptypockets
10分前
EternalPatience
11分前
Jake731
11分前
JamesF1
12分前
t1215s
14分前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。